Added by | pcoopman |
---|---|
Group name | EquipePC |
Item Type | Attachment |
Title | PubMed entry |
URL | http://www.ncbi.nlm.nih.gov/pubmed/35337692 |
Accessed | 2023/11/20 - 18:09:36 |
Date Added | 2023/11/20 - 17:09:36 |
Date Modified | 2023/11/20 - 17:09:36 |
Parent item | Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer |